HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gernot Hudelist Selected Research

Gernot Hudelist Research Topics

Disease

28Neoplasms (Cancer)
01/2017 - 02/2003
23Breast Neoplasms (Breast Cancer)
01/2017 - 02/2003
6Endometriosis
02/2022 - 10/2005
5Neoplasm Metastasis (Metastasis)
07/2014 - 01/2003
4Carcinogenesis
02/2009 - 03/2003
4Carcinoma (Carcinomatosis)
05/2007 - 03/2003
3Leiomyoma (Uterine Fibroids)
02/2012 - 10/2010
3Disease Progression
03/2006 - 01/2006
2Pelvic Pain
02/2012 - 05/2010
2Papillomavirus Infections
04/2011 - 12/2007
2Inflammation (Inflammations)
05/2010 - 10/2007
2Ductal Carcinoma
03/2009 - 03/2003
2Ovarian Neoplasms (Ovarian Cancer)
01/2006 - 03/2003
1Body Temperature Changes
02/2022
1Pathologic Constriction (Stenosis)
03/2018
1Hydronephrosis
03/2018
1Pain (Aches)
02/2016
1Tuberous Sclerosis (Bourneville's Disease)
08/2013
1Infertility (Sterility)
02/2012
1Myoma
02/2012
1Infections
01/2012
1Uterine Perforation
11/2011
1Hemorrhage
11/2011
1Lymphatic Metastasis
06/2011
1Hematoma
10/2010
1Fever (Fevers)
10/2010
1Cicatrix (Scar)
10/2010
1Noninfiltrating Intraductal Carcinoma (DCIS)
04/2010
1Heart Failure
12/2008
1Cardiotoxicity
12/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2007
1Endometrial Neoplasms (Endometrial Cancer)
01/2007
1Endometrial Stromal Sarcoma
01/2007
1Phyllodes Tumor (Cystosarcoma Phylloides)
12/2006
1Leukemia
02/2006
1Birth Weight (Birth Weights)
03/2005

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2003
9Trastuzumab (Herceptin)FDA Link
01/2017 - 02/2005
7Biological ProductsIBA
05/2010 - 04/2005
5Complementary DNA (cDNA)IBA
05/2010 - 08/2004
4Estrogen ReceptorsIBA
06/2011 - 03/2003
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2007 - 12/2004
3DNA (Deoxyribonucleic Acid)IBA
08/2013 - 01/2003
3Estrogens (Estrogen)FDA Link
06/2011 - 12/2006
3ParaffinIBA
06/2011 - 08/2004
3Messenger RNA (mRNA)IBA
07/2008 - 03/2003
3Estrogen Receptor alphaIBA
10/2005 - 03/2003
2EnzymesIBA
06/2011 - 01/2007
2Hormones (Hormone)IBA
06/2011 - 02/2009
2SulfotransferasesIBA
06/2011 - 12/2006
2Aromatase (CYP19)IBA
06/2011 - 12/2006
2ErbB Receptors (EGF Receptor)IBA
03/2009 - 12/2004
2CytokinesIBA
03/2009 - 07/2008
2LH Receptors (LH Receptor)IBA
02/2009 - 07/2008
2Monoclonal AntibodiesIBA
12/2008 - 08/2004
2Tyrosine (L-Tyrosine)FDA Link
02/2006 - 12/2004
2Estrogen Receptor betaIBA
10/2005 - 03/2003
2AntibodiesIBA
08/2004 - 03/2003
2Steroid Receptors (Steroid Receptor)IBA
10/2003 - 03/2003
2Phosphopyruvate Hydratase (Enolase)IBA
07/2003 - 03/2003
2VimentinIBA
07/2003 - 03/2003
1nasIBA
02/2016
1Cyclin-Dependent Kinase Inhibitor p27IBA
08/2013
1Tuberous Sclerosis Complex 2 ProteinIBA
08/2013
1Levonorgestrel (Plan B)FDA LinkGeneric
11/2011
1Progestins (Progestagens)IBA
11/2011
1VaccinesIBA
04/2011
1Analgesics (Analgesic Drugs)IBA
10/2010
1Anti-Bacterial Agents (Antibiotics)IBA
10/2010
1Adiponectin ReceptorsIBA
04/2010
1Carrier Proteins (Binding Protein)IBA
04/2010
1AdiponectinIBA
04/2010
1TamoxifenFDA LinkGeneric
06/2009
1ErbB-2 ReceptorIBA
12/2008
1Transcription Factors (Transcription Factor)IBA
07/2008
1Immunoglobulin M (IgM)IBA
12/2007
1Immunoglobulin G (IgG)IBA
12/2007
1Immunoglobulin A (IgA)IBA
12/2007
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2007
1Cyclin D1IBA
05/2007
1Keratin-8 (Keratin 8)IBA
05/2007
1OsteopontinIBA
05/2007
1Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2007
1estrone sulfotransferaseIBA
01/2007
1Antineoplastic Agents (Antineoplastics)IBA
03/2006
1Imatinib Mesylate (Gleevec)FDA Link
02/2006
1Insulin (Novolin)FDA Link
01/2006
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
10/2005

Therapy/Procedure

9Therapeutics
01/2017 - 01/2006
4Drug Therapy (Chemotherapy)
12/2008 - 01/2003
3Uterine Myomectomy
02/2012 - 10/2010
1Decompression
03/2018
1Minimally Invasive Surgical Procedures
03/2018
1Cystectomy
03/2018
1Cesarean Section (Caesarean Section)
01/2012
1Hysterectomy
01/2012
1Intrauterine Devices (Intrauterine Device)
11/2011
1Catheters
10/2010
1Episiotomy
03/2005
1Surgical Instruments (Clip)
03/2005